Editorial Board About Us

John P Mulhall

All articles from this author are listed below.

Volume 2, Supplement 4 Supplement

Sergery, Ultrasound, Adjuvant and Neoadjuvant Therapy

Therapeutic Strategies for Localized Prostate Cancer I:

Karl Pummer Guy Vallancien Martin E Gleave Martin I Resnick John Lynch John P Mulhall E David Crawford

Prostatic neoplasms Ultrasound Prostatectomy, radical Therapy, adjuvant

Volume 6, Supplement 6 Supplement

Treatment of Erectile Dysfunction in a Hypogonadal Male

Hypogonadism Erectile dysfunction Sildenafil citrate

Volume 7, Supplement 2 Review Articles

Cavernous Nerve Stimulation and Interposition Grafting: A Critical Assessment and Future Perspectives

Radical prostatectomy Erectile dysfunction Cavernous nerve grafting

Volume 8, Number 3 Meeting Reviews

Best of the 2006 AUA Annual Meeting

Meeting Review

Shachi Tyagi Li-Ming Su Michael E Aldridge Tobias Klatte John P Mulhall Danil V Makarov John P Stein Arie S Belldegrun Michael K Brawer Claus G Roehrborn Jacob Rajfer J Curtis Nickel Victor W Nitti Michael B Chancellor Alan W Partin Ellen Shapiro

Highlights from the 2006 Annual Meeting of the American Urological Association May 20–25, 2006 Atlanta, GA

Prostate cancer Infertility Benign prostatic hyperplasia Bladder cancer Kidney cancer Lower urinary tract symptoms Bladder exstrophy Overactive bladder Interstitial cystitis Stress urinary incontinence Peyronie’s disease Spina bifida Neurogenic bladder Erectile dysfunction Chronic pelvic pain syndrome Chronic prostatitis Tumor markers Androgen replacement therapy Ejaculatory dysfunction Anorectal malformations Renal stones Robotic-assisted radical prostatectomy

Volume 10, Number 3 Meeting Reviews

Advances in Sexual Medicine

Meeting Review

John P Mulhall Jacob Rajfer

Highlights from the 2007 Winter Meeting of the Sexual Medicine Society of North America, December 6-9, 2007, Chicago, IL [Rev Urol. 2008;10(3):232-235]

Radical prostatectomy Erectile dysfunction Phosphodiesterase type 5 inhibitors Stem cells Spinal cord injury Penile implant surgery

Volume 10, Number 1 Review Articles

Impact of Phosphodiesterase Type 5 Inhibitors on Endothelial Function

Treatment Update

Patrick E Teloken John P Mulhall

It is now known that endothelial health is essential for normal erectile function, and changes in endothelial integrity or function may lead to erectile dysfunction (ED). Because phosphodiesterase type 5 (PDE-5) inhibitors have been shown to improve endothelial function, many investigators have questioned whether PDE-5 inhibition will lead to improvement in erectile function. Data from the studies reviewed in this article show that therapy with PDE-5 inhibitors results in improvement in flow-mediated dilation, nocturnal penile tumescence and rigidity, and carotid artery intima-media thickness as well as higher scores on the Sexual Health Inventory for Men, International Index of Erectile Function, Erection Function Domain, and other instruments. Further research is needed to determine whether long-term PDE-5 inhibition can reverse ED and whether use of these agents will decrease cardiovascular morbidity in high-risk populations. [Rev Urol. 2008;10(1):26-30]

Erectile dysfunction Tadalafil Sildenafil Endothelial function Phosphodiesterase type 5inhibitors